ClassID:

21647

A61K2300/00 - page 22 - CPC Classification

Classification description:

Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups  - 

Recent Application in this class:
#6301
20120101154
2012-04-26

Compositions and methods for increasing compliance with therapies using aldehyde dehydrogenase inhibitors and treating alcoholism

#6302
20120101152
2012-04-26

Neurite elongation agent, memory-improving agent and anti-Alzheimer agent comprising 4′-demethylnobiletin or 4′-demethyltangeretin as active ingredient, and process for production of the compound

#6303
20120101151
2012-04-26

Combination therapy and uses thereof for treatment and prevention of parasitic infection and disease

#6304
20120101147
2012-04-26

INHIBITION OF HDAC2 TO PROMOTE MEMORY

#6305
20120101102
2012-04-26

Method for predicting therapeutic effect of chemotherapy on renal cell cancer

#6306
20120101089
2012-04-26

Anti-Emetic Substance

#6307
20120101080
2012-04-26

Composition for treatment of tuberculosis

#6308
20120101076
2012-04-26

CARBONATE DERIVATIVES FOR THE TREATMENT OF COUGH

#6309
20120101074
2012-04-26

Method and medication for prevention and treatment of ocular hypertension and glaucoma

#6310
20120101073
2012-04-26

Novel Method For Treating Breathing Disorders or Diseases

#6311
20120101071
2012-04-26

SubstitutedTetracycline Compounds for the Treatment of Malaria

#6312
20120101067
2012-04-26

Methods for enhancing hematopoietic progenitor cell engraftment

#6313
20120101066
2012-04-26

Pharmaceutical compositions and therapeutic methods employing a combination of a manganese complex compound and a non-manganese complex form of the compound

#6314
20120101058
2012-04-26

Pharmaceutical composition comprising mannooligosaccharides derived from coffee for treatment of lifestyle-related disease, and food useful for treatment of lifestyle-related disease

#6315
20120101057
2012-04-26

COMBINED THERAPY OF COLORECTAL CARCINOMA

#6316
20120101036
2012-04-26

Methods for treating wounds

#6317
20120101033
2012-04-26

RETINITIS PIGMENTOSA TREATMENT

#6318
20120101021
2012-04-26

COMPOSITIONS, FORMULATIONS AND METHODS OF TREATING PREECLAMPSIA-TYPE DISORDERS OF PREGNANCY

#6319
20120100608
2012-04-26

LYMPHOCREME

#6320
20120100248
2012-04-26

NUTRITIONAL COMPOSITION COMPRISING CEREAL BETA-GLUCAN AND SALACIA EXTRACT

#6321
20120100231
2012-04-26

Antimicrobial Compositions And Methods Of Making And Using The Same

#6322
20120100229
2012-04-26

Treatment and Prevention of White Matter Injury with KATP Channel Activators

#6323
20120100227
2012-04-26

KINASE PROTEIN BINDING INHIBITORS

#6324
20120100223
2012-04-26

Lipid-containing compositions and methods of use thereof

#6325
20120100221
2012-04-26

PHARMACEUTICAL COMPOSITIONS CONTAINING A COMBINATION OF AN ANTIHISTAMINE AND A DECONGESTANT

#6326
20120100218
2012-04-26

Intralymphatic Chemotherapy Drug Carriers

#6327
20120100209
2012-04-26

CONTROLLED RELEASE COMPOSITIONS COMPRISING A COMBINATION OF ISOSORBIDE DINITRATE AND HYDRALAZINE HYDROCHLORIDE

#6328
20120100204
2012-04-26

TGF-Beta Stimulating Agent Compositions and Combinations

#6329
20120100171
2012-04-26

HAPTEN-CARRIER CONJUGATES WITH BACTERIAL TOXINS HAVING A SIGNAL PEPTIDE AS CARRIER AND THEIR USE IN IMMUNOGENIC COMPOSITIONS

#6330
20120100162
2012-04-26

Cyclophosphamide in combination with immune therapeutics

#6331
20120100154
2012-04-26

Anti-CCL25 and anti-CCR9 antibodies for the prevention and treatment of cancer and cancer cell migration

#6332
20120100138
2012-04-26

THE USE OF INHIBITORS OF BRUTON'S TYROSINE KINASE (BTK)

#6333
20120100136
2012-04-26

METHODS FOR TREATING OR PREVENTING OPHTHALMOLOGICAL DISEASES

#6334
20120100125
2012-04-26

LOCAL DEHYDRATION FOR CARPAL TUNNEL SYNDROME

#6335
20120100123
2012-04-26

COMPOSITIONS AND METHODS FOR THE PREVENTION OF CARDIOVASCULAR DISEASE

#6336
20120100122
2012-04-26

Combination therapy using coenzyme Q10 and a caffeic acid-derived ester

#6337
20120100109
2012-04-26

Method for increasing the replication of oncolytic HSVs in highly resistant tumor cells using mTOR pathway and PI3K inhibitors

#6338
20120100107
2012-04-26

IN VIVO TRANSFER METHODS FOR WOUND HEALING

#6339
20120100106
2012-04-26

COLLAGEN-BINDING SYNTHETIC PEPTIDOGLYCANS FOR WOUND HEALING

#6340
20120100105
2012-04-26

AGENT AND METHOD FOR TREATING REFRACTORY CHRONIC HEPATITIS C

#6341
20120100100
2012-04-26

CYCLIN DEPENDENT KINASE INHIBITORS AND METHODS OF USE

#6342
20120100088
2012-04-26

Apigenin-containing composition

#6343
20120100081
2012-04-26

Composition and method for treating wounds

#6344
20120100068
2012-04-26

Anti-CD74 immunoconjugates and methods of use

#6345
20120096569
2012-04-19

ANTI-IL-6 ANTIBODIES,COMPOSITIONS, METHODS AND USES

#6346
20120095439
2012-04-19

Implantable therapeutic device

#6347
20120095277
2012-04-19

Methods and compositions for inhibition of multi-drug resistance by hyaluronan oligomers

#6348
20120095104
2012-04-19

USE OF VASOCONSTRICTORS

#6349
20120095088
2012-04-19

Medicinal cannabis uniform in food

#6350
20120095063
2012-04-19

METHODS AND COMPOSITIONS FOR TREATMENT OF ISCHEMIC CONDITIONS AND CONDITIONS RELATED TO MITOCHONDRIAL FUNCTION

#6351
20120095059
2012-04-19

Compositions and Methods for Treating Type II Diabetes and Related Disorders

#6352
20120095052
2012-04-19

PAR-1 ANTAGONISM IN FED OR ANTACID-DOSED PATIENTS

#6353
20120095045
2012-04-19

Injectable anticancer composition for local administration containing hydroxychloroquine

#6354
20120095043
2012-04-19

Triglyceride-lowering agent and hyperinsulinism-ameliorating agent

#6355
20120095041
2012-04-19

Reversible nondepolarizing neuromuscular blockade agents and methods for their use

#6356
20120095028
2012-04-19

3-OXA-7-AZABICYCLO[3.3.1]NONANES

#6357
20120095026
2012-04-19

Inhibitors of Bruton's tyrosine kinase

#6358
20120095019
2012-04-19

METHODS AND FORMULATIONS OF TREATING THROMBOSIS WITH BETRIXABAN AND A P-GLYCOPROTEIN INHIBITOR

#6359
20120095018
2012-04-19

Method of treating neurodegenerative diseases

#6360
20120094990
2012-04-19

Phenylacetic acid compound

#6361
20120094985
2012-04-19

PHARMACEUTICAL COMPOSITIONS COMPRISING CHLOROPHENYL PIPERAZINE DERIVED COMPOUNDS AND USE OF THE COMPOUNDS IN PRODUCING MEDICAMENTS

#6362
20120094977
2012-04-19

Compositions and methods for the treatment of disease associated with TRP-P8 expression

#6363
20120094967
2012-04-19

Compositions and methods for treating asthma and other lung diseases

#6364
20120094966
2012-04-19

Optionally substituted 3-amino-4-(thioxo or imino)-4,5-dihydro-2H-pyrazolo [3,4-d]pyrimidin-6(7H)-ones

#6365
20120094964
2012-04-19

SULFAMOYL BENZOIC ACID DERIVATIVES AS TRPM8 ANTAGONISTS

#6366
20120094960
2012-04-19

DOSAGE FORMS OF RISEDRONATE

#6367
20120094959
2012-04-19

TREATMENT OF CYSTIC DISEASES

#6368
20120094956
2012-04-19

Treatment of cancer with specific RXR agonists

#6369
20120094951
2012-04-19

COMPOSITIONS

#6370
20120094947
2012-04-19

Therapy of tumors and infectious agents deficient in methylthioadenosine phosphorylase

#6371
20120094942
2012-04-19

Chemosensory receptor ligand-based therapies

#6372
20120094932
2012-04-19

Macrocyclic lactone compounds and methods for their use

#6373
20120094927
2012-04-19

Therapy for MLL-rearranged leukemia

#6374
20120094907
2012-04-19

Peptide therapy for increasing platelet levels

#6375
20120094905
2012-04-19

Method for treating hyperglycemia with GLP-1

#6376
20120094894
2012-04-19

ANTIDIABETIC MEDICATIONS COMPRISING A DPP-4 INHIBITOR (LINAGLIPTIN) OPTIONALLY IN COMBINATION WITH OTHER ANTIDIABETICS

#6377
20120093975
2012-04-19

L-ARABINOSE PLUS CHROMIUM FOR CONTROLLING THE METABOLIZATION OF SUCROSE

#6378
20120093951
2012-04-19

TRADITIONAL CHINESE MEDICINE COMPOSITION FOR TREATING SWINE INFLUENZA, PREPARATION METHOD AND USE THEREOF

#6379
20120093950
2012-04-19

COMPOSITIONS AND METHODS FOR TREATING, INHIBITING THE ONSET, AND SLOWING THE PROGRESSION OF ERECTILE DYSFUNCTION INCLUDING NATURALLY OCCURING AGE RELATED ERECTILE DYSFUNCTION

#6380
20120093949
2012-04-19

SYSTEMS AND METHODS FOR TREATING LICE

#6381
20120093947
2012-04-19

METHOD OF TREATING REACTIVE AIRWAY DISEASE

#6382
20120093945
2012-04-19

Method for treating an inflammation or lesion caused by a virus

#6383
20120093942
2012-04-19

Pharmaceutical composition for treating nephropathy and healthy food comprising herb extracts

#6384
20120093941
2012-04-19

Neutrophil-depleted platelet rich plasma formulations for cardiac treatments

#6385
20120093937
2012-04-19

Encapsulated liver cell composition

#6386
20120093923
2012-04-19

Apparatus And Methods For Delivering A Plurality Of Medicaments For Management Of Co-Morbid Diseases, Illnesses, Or Conditions

#6387
20120093922
2012-04-19

PHARMACEUTICAL COMPOSITIONS COMPRISING EPA AND A CARDIOVASCULAR AGENT AND METHODS OF USING THE SAME

#6388
20120093919
2012-04-19

E2F as a target of hormone refractory prostate cancer

#6389
20120093918
2012-04-19

Compositions comprising a radiosensitizer and an anti-cancer agent and methods of uses thereof

#6390
20120093898
2012-04-19

Metal ion nanoclusters

#6391
20120093891
2012-04-19

Macrocyclic lactone compounds and methods for their use

#6392
20120093889
2012-04-19

Layered pharmaceutical formulations

#6393
20120093888
2012-04-19

Micro-emulsions for the treatment of rheumatic disorders

#6394
20120093878
2012-04-19

PHARMACEUTICAL COMPOSITIONS CONTAINING A BIGUANIDE AND A THIAZOLIDINEDIONE

#6395
20120093838
2012-04-19

Gene detection assay for improving the likelihood of an effective response to a HER2 antibody cancer therapy

#6396
20120093827
2012-04-19

TREATMENT OF AUTOIMMUNE DISORDERS WITH A NEUROTOXIN

#6397
20120093826
2012-04-19

Fully human antibodies specific to CADM1

#6398
20120093818
2012-04-19

Monoclonal antibodies to proprotein convertase subtilisin kexin type 9 (PCSK9)

#6399
20120093816
2012-04-19

Use of TNF-alpha Inhibitors for Treating a Nerve Disorder Mediated by Nucleus Pulposus

#6400
20120093809
2012-04-19

USE OF ALKANOYL L-CARNITINE IN COMBINATION WITH CHEMOTHERAPEUTIC AGENTS FOR THE TREATMENT OF NEOPLASMS

#6401
20120093806
2012-04-19

ANTITUMOR COMBINATIONS CONTAINING ANTIBODIES RECOGNIZING SPECIFICALLY CD38 AND CYTARABINE

#6402
20120093798
2012-04-19

Methods for treatment of stroke or cerebrovascular accidents using an ETB receptor agonist

#6403
20120093797
2012-04-19

COMBINED USE OF CREATINE PHOSPHATE AND CREATINE PHOSPHOKINASE FOR TREATMENT OF ARTERIOSCLEROSIS

#6404
20120093792
2012-04-19

Immunotherapy for pancreatic cancer

#6405
20120093779
2012-04-19

COMPLEX MICROBIAL PREPARATION FOR TREATING DIABETES AND PREPARATIVE METHOD AND USE THEREOF

#6406
20120093770
2012-04-19

Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases

#6407
20120093759
2012-04-19

Medical Devices, Wound Dressings, and Methods for Dressing Wounds

#6408
20120093752
2012-04-19

Use of monoamine oxidase inhibitors to improve epithelial biology

#6409
20120093740
2012-04-19

Peptide fragments for inducing synthesis of extracellular matrix proteins

#6410
20120089076
2012-04-12

Methods of treatment using anti-IL-20 antibodies

#6411
20120088912
2012-04-12

Inhibitors of Bruton's tyrosine kinase

#6412
20120088904
2012-04-12

ANALYSIS OF HCV GENOTYPES

#6413
20120088833
2012-04-12

Modified amino acid for the inhibition of platelet aggregation

#6414
20120088830
2012-04-12

Satiety-inducing composition

#6415
20120088820
2012-04-12

PHARMACEUTICAL COMPOSITION FOR TREATING AND PREVENTING DISEASES RELATED TO JOINTS AND CONNECTIVE TISSUE

#6416
20120088807
2012-04-12

INTERLACED METHOD FOR TREATING CANCER OR A PRECANCEROUS CONDITION

#6417
20120088804
2012-04-12

Clevidipine emulsion formulations containing antimicrobial agents

#6418
20120088796
2012-04-12

Compounds that inhibit (block) bitter taste in composition and use thereof

#6419
20120088786
2012-04-12

Immediate release pharmaceutical compositions comprising oxycodone and naloxone

#6420
20120088777
2012-04-12

Method of treating down's syndrome

#6421
20120088776
2012-04-12

Treatment of mammalian disorders mediated by alpha-carbonic anhydrase isoforms

#6422
20120088773
2012-04-12

Circadian rhythm modulation

#6423
20120088744
2012-04-12

COMPOSITIONS FOR TREATING CMT AND RELATED DISORDERS

#6424
20120088743
2012-04-12

COMBINATIONS COMPRISING ANTIMUSCARINIC AGENTS AND PDE4 INHIBITORS

#6425
20120088740
2012-04-12

Co-crystals and pharmaceutical compositions comprising the same

#6426
20120088725
2012-04-12

5-CNAC as oral delivery agent for parathyroid hormone fragments

#6427
20120088671
2012-04-12

Anti-biofilm compositions and methods for using

#6428
20120088255
2012-04-12

HER-2 BINDING ANTAGONISTS

#6429
20120087998
2012-04-12

Treatment of inflammatory bowel disease

#6430
20120087997
2012-04-12

EDIBLE PRODUCTS WITH THERMOSTATIC AND COGNITIVE EFFECTS

#6431
20120087996
2012-04-12

Antioxidant skin care compositions

#6432
20120087994
2012-04-12

SYSTEMIC ADMINISTRATION OF NAC AS AN ADJUNCT IN THE TREATMENT OF BIOTERROR EXPOSURES SUCH AS SMALLPOX AND USE IN COMBINATION WITH DHEA FOR THE TREATMENT OF SMALLPOX

#6433
20120087992
2012-04-12

miRNAS AS THERAPEUTIC TARGETS IN CANCER

#6434
20120087991
2012-04-12

MUCOSITIS PREVENTION SUPPLEMENT AND TREATMENT

#6435
20120087980
2012-04-12

STIMULATION OF NEUROREGENERATION BY FLAVONOID GLYCOSIDES

#6436
20120087956
2012-04-12

Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries

#6437
20120087953
2012-04-12

PHARMACEUTICAL COMPOSITIONS OF ACTIVE PHARMACEUTICAL INGREDIENT COMPRISING SULPHONYLUREA MOIETY WITH EXCELLENT DISSOLUTION PROPERTIES

#6438
20120087942
2012-04-12

Compositions of marine botanicals to provide nutrition to aging and environmentally damaged skin

#6439
20120087941
2012-04-12

Compositions of marine botanicals to provide nutrition to aging and environmentally damaged skin

#6440
20120087934
2012-04-12

COADMINISTRATION OF ALPHA-FETOPROTEIN AND AN IMMUNOMODULATORY AGENT TO TREAT MULTIPLE SCLEROSIS

#6441
20120087923
2012-04-12

Methods for treating bone loss with antibodies to OPGL

#6442
20120087918
2012-04-12

Methods and compositions for inhibiting the growth of hematopoietic malignant cells

#6443
20120087915
2012-04-12

USE OF INHIBITORS OF BRUTON'S TYROSINE KINASE (BTK)

#6444
20120087913
2012-04-12

Induction of tumor hypoxia for cancer therapy

#6445
20120087904
2012-04-12

Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of skin cancer

#6446
20120087893
2012-04-12

Combinations of a HCV inhibitor such as bicyclic pyrrole derivatives and a therapeutic agent

#6447
20120087878
2012-04-12

Botanical formulations

#6448
20120087877
2012-04-12

COMPOSITION BASED ON MINERAL CONCENTRATES DERIVED FROM PRECIOUS STONES

#6449
20120087876
2012-04-12

AVERMECTIN/METRONIDAZOLE COMPOSITIONS FOR TREATING AFFLICTIONS OF THE SKIN, E.G., ROSACEA

#6450
20120083828
2012-04-05

Apparatus and method for delivery of biological sealant

#6451
20120083772
2012-04-05

CORNEAL TREATMENT SYSTEM AND METHOD

#6452
20120083747
2012-04-05

Vaginal renewal complex and applicator

#6453
20120083534
2012-04-05

OPHTHALMIC AND CONTACT LENS SOLUTION

#6454
20120083524
2012-04-05

Oral Composition Comprising DHA and Genistein for Enhancing Skin Properties

#6455
20120083516
2012-04-05

Nasal sinus spray for treatment of sinus headache and method of using same

#6456
20120083508
2012-04-05

ALPHA-2B RECEPTOR AGONIST AND ANTICONVULSANT COMPOSITIONS FOR TREATING CHRONIC PAIN

#6457
20120083503
2012-04-05

Method for predicting therapeutic efficacy of chemotherapy on non-small-cell lung cancer

#6458
20120083498
2012-04-05

Modulators of Viral Transcription, and Methods and Compositions Therewith

#6459
20120083487
2012-04-05

COMBINATION OF MORPHINAN COMPOUNDS AND ANTIDEPRESSANT FOR THE TREATMENT OF PSEUDOBULBAR AFFECT, NEUROLGICAL DISEASES, INTRACTABLE AND CHRONIC PAIN AND BRAIN INJURY

#6460
20120083486
2012-04-05

KIT, COMPOSITION, PRODUCT OR MEDICAMENT FOR TREATING COGNITIVE IMPAIRMENT

#6461
20120083485
2012-04-05

NORIBOGAINE IN THE TREATMENT OF PAIN AND DRUG ADDICTION

#6462
20120083479
2012-04-05

Compositions comprising azelastine and methods of use thereof

#6463
20120083468
2012-04-05

METHOD FOR PREPARING A MEDICAL SOLUTION FOR THE MANUFACTURE OF A MEDICAMENT FOR PERITONEAL DIALYSIS

#6464
20120083457
2012-04-05

Bortezomib formulations

#6465
20120083453
2012-04-05

TREATMENT USING NEUBLASTIN POLYPEPTIDES

#6466
20120083452
2012-04-05

Topical Anesthetic Uses of Szeto-Schiller Peptides

#6467
20120083447
2012-04-05

Novel Therapeutic Treatments Using Centhaquin

#6468
20120083443
2012-04-05

Control of ATP Release by Red Blood Cells and Therapeutic Applications Thereof

#6469
20120082742
2012-04-05

METHOD AND COMPOSITIONS FOR TREATING CUTANEOUS VERRUCAE

#6470
20120082741
2012-04-05

Compositions and methods for the prevention and treatment of red blood cell coagulation

#6471
20120082739
2012-04-05

Compositions and Methods for Treatment and Management of Pain

#6472
20120082736
2012-04-05

Small-molecule TNF modulator to reduce the side effects of chemotherapy and radiotherapy

#6473
20120082735
2012-04-05

Allergic skin desease topical cream

#6474
20120082730
2012-04-05

Nanoparticulate in-situ gels of TPGS, gellan and PVA as vitreous humor substitutes

#6475
20120082720
2012-04-05

Compositions For Treating Chronic Viral Infections

#6476
20120082719
2012-04-05

Compositions For Treating Chronic Viral Infections

#6477
20120082717
2012-04-05

COMPLEX, MULTILAYER USING THE SAME, AND DEVICE COATED WITH THE MULTILAYER

#6478
20120082705
2012-04-05

Tetra calcium phosphate based organophosphorus compositions and methods

#6479
20120082703
2012-04-05

Pharmaceutical composition and use of the pharmaceutical composition for the treatment, prophylaxis or prevention of neoplastic diseases in humans and animals

#6480
20120082700
2012-04-05

Compositions for stimulation of mammalian innate immune resistance to pathogens

#6481
20120082695
2012-04-05

COSMETIC ACTIVE PREPARATION

#6482
20120082690
2012-04-05

CHAPERONIN 10 IMMUNOSUPPRESSION

#6483
20120082659
2012-04-05

Methods And Compositions Related To Synergistic Responses To Oncogenic Mutations

#6484
20120082656
2012-04-05

COMPOSITION COMPRISING THE PURIFIED EXTRACT OF BEE VENOM FOR PREVENTING AND TREATING DEGENERATIVE BRAIN DISEASE

#6485
20120082655
2012-04-05

Downregulation of SPY1 by p53 as an essential component of p53-mediated effects

#6486
20120082653
2012-04-05

Methods of lysosomal storage disease therapy

#6487
20120082649
2012-04-05

PERIVASCULAR MESENCHYMAL PRECURSOR CELLS

#6488
20120082647
2012-04-05

INTERFERON-BETA FOR USE AS MONOTHERAPY OR IN COMBINATION WITH OTHER CANCER THERAPIES

#6489
20120082644
2012-04-05

CYTOKINES AND NEUROANTIGENS FOR TREATMENT OF IMMUNE DISORDERS

#6490
20120082642
2012-04-05

Reversal of Adult Onset Disorders with Granulocyte-Colony Stimulating Factors

#6491
20120082634
2012-04-05

Treatment for dyslipidemia

#6492
20120082632
2012-04-05

Topical drug delivery system with dual carriers

#6493
20120082627
2012-04-05

OTIC FOAM FORMULATIONS

#6494
20120082626
2012-04-05

USE OF R-BAMBUTEROL AS INHALED MEDICAMENT AND COMBINATION THERAPIES FOR TREATMENT OF RESPIRATORY DISORDERS

#6495
20120082625
2012-04-05

COMBINATION TREATMENT FOR ROSACEA

#6496
20120082620
2012-04-05

Methods and compositions for treatment of ADD/ADHD, depression, memory problems and other conditions

#6497
20120082618
2012-04-05

Prostate cancer diagnosis and treatment

#6498
20120077877
2012-03-29

Medium chain peroxycarboxylic acid compositions

#6499
20120077875
2012-03-29

Composition including at least one trans-cinnamaldehyde and the use thereof in the treatment of bacterial infections, specifically in the treatment of nosocomial infections

#6500
20120077868
2012-03-29

Use of toll-like receptor-9 agonists

#6501
20120077856
2012-03-29

PHARMACEUTICAL PRODUCT

#6502
20120077845
2012-03-29

Estrogen receptor ligands and methods of use thereof

#6503
20120077837
2012-03-29

ANTI-TUMOR AGENT

#6504
20120077829
2012-03-29

PARENTERAL SOLUTIONS CONTAINING METOLAZONE

#6505
20120077828
2012-03-29

CHEMICAL COMPOUNDS

#6506
20120077818
2012-03-29

COMPOSITIONS COMPRISING TRANSNORSERTRALINE AND SEROTONIN RECEPTOR 1A AGONISTS/ANTAGONISTS AND USES THEREOF

#6507
20120077808
2012-03-29

Niacin mimetics, and methods of use thereof

#6508
20120077803
2012-03-29

Uses Of NK Receptor Antagonists

#6509
20120077786
2012-03-29

METHODS AND COMPOSITIONS FOR DISEASE TREATMENT USING INHALATION

#6510
20120077784
2012-03-29

Skin treatment compositions

#6511
20120077783
2012-03-29

Materials and methods for treatment and diagnosis of disorders associated with oxidative stress

#6512
20120077782
2012-03-29

METHOD OF ACTIVATION OF OXAZAPHOSPHORINES

#6513
20120077773
2012-03-29

Treatment of oral mucositis by administering an ionic complex of chitosan and a negatively charged polysaccharide selected from heparin, heparan sulfate and dextran sulfate

#6514
20120077772
2012-03-29

Solid oral dosage forms of lamivudine

#6515
20120077771
2012-03-29

COMPOSITIONS FOR USE IN CARDIOPLEGIA COMPRISING ESMOLOL AND ADENOSINE

#6516
20120077769
2012-03-29

Topical ophthalmic compositions containing tobramycin and dexamethasone

#6517
20120077763
2012-03-29

Methods for treating heart failure by inhibiting the mitochondrial sodium-calcium exchanger (mNCE)

#6518
20120077762
2012-03-29

Combined and extracts for the therapeutic treatment of heart failure

#6519
20120077761
2012-03-29

COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF CORONARY HEART DISEASES

#6520
20120077756
2012-03-29

Methods, compositions, and kits for the treatment of ophthalmic disorders

#6521
20120077755
2012-03-29

Compounds for, and methods of, treating cancer and inhibiting invasion and metastases

#6522
20120077748
2012-03-29

Materials and methods for improving gastrointestinal function

#6523
20120077744
2012-03-29

STEROID-SPARING METHODS OF TREATING BRAIN EDEMA

#6524
20120077741
2012-03-29

Treatment of Central Nervous System Disorders

#6525
20120076878
2012-03-29

Compositions and methods for the prevention and treatment of brain diseases and conditions

#6526
20120076874
2012-03-29

Composition with improved bioavailabilty of saponin and method for improving the bioavailability of saponin

#6527
20120076867
2012-03-29

Petroleum-free compositions for skin care and other applications, and methods of making same

#6528
20120076862
2012-03-29

Methods of enhancing drug delivery and effectiveness of therapeutic agents

#6529
20120076854
2012-03-29

Cellular compositions for use in therapy

#6530
20120076852
2012-03-29

Drug carrier and drug carrier kit for inhibiting fibrosis

#6531
20120076849
2012-03-29

PLANT COMPOSITION FOR THE TREATMENT OR PREVENTION OF VIRAL BLOOD-BORNE DISEASES SUCH AS DISEASES CAUSED BY THE HUMAN IMMUNODEFICIENCY VIRUS (HIV) OR HEPATITIS C

#6532
20120076848
2012-03-29

METHOD AND SYSTEM FOR EFFECTING CHANGES IN PIGMENTED TISSUE

#6533
20120076787
2012-03-29

COMBINATION OF A TNF-ALPHA ANTAGONIST AND A VEGF ANTAGONIST FOR USE IN THE TREATMENT OR PREVENTION OF DISEASES OF THE EYE

#6534
20120076775
2012-03-29

Combination of HGF Inhibitor and EGF Inhibitor to Treat Cancer

#6535
20120076770
2012-03-29

Modulation of autophagy and and serotonin for treatment of multiple myeloma related diseases

#6536
20120076769
2012-03-29

HERBAL COMPOSITION FOR CANCER TREATMENT

#6537
20120076766
2012-03-29

Topical drug delivery system with dual carriers

#6538
20120076764
2012-03-29

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR HEALING WOUNDS

#6539
20120076756
2012-03-29

Benzimidazole derivatives

#6540
20120076755
2012-03-29

Hepatitis C virus inhibitors

#6541
20120076742
2012-03-29

Topical drug delivery system with dual carriers

#6542
20120076739
2012-03-29

Combination of anticholinergics, β2-adrenoceptor agonists, antileukotrienes (leukotriene receptor antagonists), glucocorticoids and/or phosphodiesterase 4 inhibitors for the treatment of inflammatory diseases

#6543
20120076738
2012-03-29

COMBINATION TREATMENT FOR DERMATOLOGICAL CONDITIONS

#6544
20120074026
2012-03-29

Pharmaceutical foam

#6545
20120073578
2012-03-29

Low-dose transdermal patches with high drug release

#6546
20120073577
2012-03-29

COMBINATION PRESSURE THERAPY FOR TREATMENT OF ISCHEMIA AND HEART CONDITIONS, DIABETES, ALZHEIMER'S DISEASE AND CANCER

#6547
20120073473
2012-03-29

Different types of mineral matter containing carbonate with reduced fossil fuel carbon dioxide emission on breakdown, together with their synthesis process and their uses

#6548
20120073001
2012-03-22

METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING PRURITIS

#6549
20120071860
2012-03-22

Dendritic cell tumor injection (DCTI) therapy

#6550
20120071550
2012-03-22

Synergistic combinations of cartonoids and polyphenols

#6551
20120071545
2012-03-22

Compositions of, and methods for, alpha-1 anti trypsin Fc fusion molecules

#6552
20120071524
2012-03-22

Compounds for treatment of cancer

#6553
20120071507
2012-03-22

Treatment regimen utilizing neratinib for breast cancer

#6554
20120071498
2012-03-22

Therapeutic composition to treat lesions caused by herpes simplex virus

#6555
20120071484
2012-03-22

Topical parasiticide composition

#6556
20120071483
2012-03-22

Therapeutic approaches for treating alzheimer disease and related disorders through a modulation of cell stress response

#6557
20120071465
2012-03-22

Mitochondrial activity inhibitors of cancer-initiating cells and use thereof

#6558
20120071458
2012-03-22

METHODS FOR TREATING OBESITY

#6559
20120071457
2012-03-22

Metallo-β-lactamase inhibitors

#6560
20120071452
2012-03-22

COMBINATIONS COMPRISING ANTIMUSCARINIC AGENTS AND CORTICOSTERIODS

#6561
20120071451
2012-03-22

METHOD OF TREATING NONALCOHOLIC STEATOHEPATITIS WITH ELEVATED DOSES OF URSODEOXYCHOLIC ACID

#6562
20120071445
2012-03-22

Combination therapy for the treatment of multiple myeloma

#6563
20120071444
2012-03-22

Method and composition for the control of ectoparasites

#6564
20120071435
2012-03-22

Pharmaceutical combinations for treatment of specific cancers

#6565
20120071434
2012-03-22

Substituted nucleotide analogs

#6566
20120071421
2012-03-22

Therapy with enterotoxin to treat ovarian and uterine cancer

#6567
20120071417
2012-03-22

Methods of inhibiting cancer cell growth with HDAC inhibitors and methods of screening for HDAC10 inhibitors

#6568
20120071410
2012-03-22

CALCITONIN PRODUCTS AND THERAPIES FOR TREATING INFLAMMATORY OR DEGENERATIVE DISEASES

#6569
20120071408
2012-03-22

HCG formulations for achieving weight loss

#6570
20120071403
2012-03-22

Methods for treating extreme insulin resistance in patients resistant to previous treatment with other anti-diabetic drugs employing an SGLT2 inhibitor and compositions thereof

#6571
20120071401
2012-03-22

AMYLIN AGONIST COMPOUNDS FOR ESTROGEN-DEFICIENT MAMMALS

#6572
20120071397
2012-03-22

Methods for Hematopoietic Stem Cell Transplantation

#6573
20120071349
2012-03-22

Anti-aging agents and methods to identify them

#6574
20120071347
2012-03-22

COMPOSITIONS AND METHODS FOR MONITORING AND DETECTING CANCEROUS CONDITIONS

#6575
20120070518
2012-03-22

METHODS AND COMPOSITIONS FOR TREATING PSORIASIS

#6576
20120070517
2012-03-22

Pharmaceutical composition containing herbal extract for prevention or treatment of nephritis

#6577
20120070514
2012-03-22

AROMATASE INHIBITOR

#6578
20120070507
2012-03-22

Compositions and Methods for the Treatment of Soft Tissue Injury

#6579
20120070506
2012-03-22

Animal Treatment

#6580
20120070502
2012-03-22

Methods of treating cancer

#6581
20120070501
2012-03-22

Method of treatment comprising administering controlled release melatonin

#6582
20120070489
2012-03-22

COMBINATION THERAPY FOR TREATMENT OF FIV INFECTION

#6583
20120070487
2012-03-22

ALKYLSACCHARIDE COMPOSITIONS WITH NUTRACEUTICALS

#6584
20120070473
2012-03-22

Apparatus and Method for Reducing the Occurrence of Post-Surgical Adhesions

#6585
20120070471
2012-03-22

ADMINISTRATION OF ENOXOPARIN SODIUM TO PATIENTS 75 YEARS AND OLDER WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION

#6586
20120070468
2012-03-22

REMOVAL OF TOXINS FROM GASTROINTESTINAL FLUIDS

#6587
20120070467
2012-03-22

Ophthalmic drug delivery

#6588
20120070462
2012-03-22

Targeted gene delivery to dendritic cells

#6589
20120070438
2012-03-22

Methods for treating melanoma

#6590
20120070432
2012-03-22

TREATMENT OF PANCREATIC CANCER USING A DR5 AGONIST IN COMBINATION WITH GEMCITABINE

#6591
20120070423
2012-03-22

ORAL COMPOSITION AND METHOD OF FORMING AND USING SAME

#6592
20120070417
2012-03-22

ANTI-INFLUENZA FORMULATIONS AND METHODS

#6593
20120070415
2012-03-22

Azido nucleosides and nucleotide analogs

#6594
20120070412
2012-03-22

HCV inhibitor and therapeutic agent combinations

#6595
20120070411
2012-03-22

SUBSTITUTED NUCLEOTIDE ANALOGS

#6596
20120070407
2012-03-22

Therapy for promoting cell growth

#6597
20120070404
2012-03-22

Increasing cancer patient survival time by administration of dithio-containing compounds

#6598
20120070390
2012-03-22

Topical drug delivery system with dual carriers

#6599
20120070368
2012-03-22

Methods of Using C-Met Modulators

#6600
20120065992
2012-03-15

SYSTEM AND METHODS FOR PHARMACY MANAGEMENT OF DRUGS